- Home
- Results news
- Hindcon Chemicals
- Q2 FY27 results
Hindcon Chemicals Q2 FY27 results: net profit up 70.8% to ₹1.23 crore, revenue up 43.5%
Hindcon Chemicals Limited reported consolidated revenue of ₹21.98 crore in Q2 FY27, up 43.5% from ₹15.32 crore a year earlier. Net profit rose 70.8% to ₹1.23 crore and basic EPS increased to ₹0.37, although profit declined from Q1 FY27 as the EBITDA margin fell to 7.0% from 14.4%.
Key points
- Consolidated revenue was ₹21.98 crore in Q2 FY27, up 43.5% from ₹15.32 crore in Q2 FY26.
- EBITDA rose 105.3% to ₹1.54 crore from ₹0.75 crore, while the EBITDA margin expanded to 7.0% from 4.9%.
- Net profit increased 70.8% to ₹1.23 crore from ₹0.72 crore, and basic EPS rose to ₹0.37 from ₹0.19.
- Against Q1 FY27, revenue increased 3.2%, but net profit fell 47.4% and the EBITDA margin declined by 7.4 percentage points.
- In H1 FY27, revenue rose 43.3% to ₹43.27 crore and net profit increased 71.6% to ₹3.57 crore.
How did Hindcon Chemicals perform in Q2 FY27?
On a consolidated basis, Hindcon Chemicals reported revenue of ₹21.98 crore for the July–September 2026 quarter, up ₹6.66 crore or 43.5% from ₹15.32 crore in Q2 FY26. EBITDA was ₹1.54 crore, up ₹0.79 crore or 105.3%, and the margin increased to 7.0% from 4.9%.
Net profit was ₹1.23 crore, up ₹0.51 crore or 70.8% from ₹0.72 crore, while profit attributable to owners rose to ₹1.40 crore from ₹0.73 crore. Basic EPS was ₹0.37, against ₹0.19. On a standalone basis, revenue was ₹21.9 crore and profit after tax was ₹1.49 crore.
Revenue rose 3.2% from ₹21.29 crore in Q1 FY27, but EBITDA fell 49.7% to ₹1.54 crore from ₹3.06 crore. The margin declined to 7.0% from 14.4%, while net profit fell 47.4% to ₹1.23 crore and basic EPS fell to ₹0.37 from ₹0.63. The board approved the unaudited results on 5 November 2026.
| ₹ crore | Q2 FY27 | Q1 FY27 | Q2 FY26 | YoY | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 21.98 | 21.29 | 15.32 | +43.5% | +3.2% |
| Other income | 0.56 | 0.62 | 0.55 | +1.8% | −9.7% |
| Total expenses | 20.79 | 18.63 | 14.90 | +39.5% | +11.6% |
| EBITDA | 1.54 | 3.06 | 0.75 | +105.3% | −49.7% |
| EBITDA margin | 7.0% | 14.4% | 4.9% | +2.1 pp | −7.4 pp |
| Profit before tax | 1.75 | 3.29 | 0.97 | +80.4% | −46.8% |
| Tax | 0.52 | 0.95 | 0.25 | +108.0% | −45.3% |
| Net profit | 1.23 | 2.34 | 0.72 | +70.8% | −47.4% |
| EPS (₹) | 0.37 | 0.63 | 0.19 | +94.7% | −41.3% |
EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).
What changed in Hindcon Chemicals' costs and profit?
Total expenses rose ₹5.89 crore or 39.5% to ₹20.79 crore from ₹14.90 crore in Q2 FY26. Cost of materials was the largest increase, rising ₹5.42 crore or 47.8% to ₹16.75 crore, while other expenses increased ₹0.57 crore or 31.5% to ₹2.38 crore.
Employee cost rose ₹0.14 crore or 9.7% to ₹1.58 crore, while depreciation increased ₹0.09 crore or 39.1% to ₹0.32 crore. Finance costs declined by ₹0.07 crore or 70.0% to ₹0.03 crore. Other income was ₹0.56 crore, up ₹0.01 crore or 1.8%, and there was no exceptional item.
Profit before tax increased ₹0.78 crore or 80.4% to ₹1.75 crore from ₹0.97 crore. Tax rose ₹0.27 crore or 108.0% to ₹0.52 crore from ₹0.25 crore, and the net profit margin increased to 5.6% from 4.7%. The filing does not state the reasons for the movements in costs, income or tax.
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Change % |
|---|---|---|---|---|
| Cost of materials | 16.75 | 11.33 | +5.42 | +47.8% |
| Employee cost | 1.58 | 1.44 | +0.14 | +9.7% |
| Finance costs | 0.03 | 0.10 | −0.07 | −70.0% |
| Depreciation | 0.32 | 0.23 | +0.09 | +39.1% |
| Other expenses | 2.38 | 1.81 | +0.57 | +31.5% |
| Total expenses | 20.79 | 14.90 | +5.89 | +39.5% |
| Other income | 0.56 | 0.55 | +0.01 | +1.8% |
| Tax | 0.52 | 0.25 | +0.27 | +108.0% |
Source: Company's results filing (XBRL).
How did the first half of FY27 go?
In the first half of FY27, Hindcon Chemicals reported consolidated revenue of ₹43.27 crore, up ₹13.08 crore or 43.3% from ₹30.19 crore in H1 FY26. Total income increased 42.6% to ₹44.45 crore from ₹31.18 crore, and EBITDA was ₹1.54 crore for the quarter.
Profit before tax for H1 FY27 rose 76.8% to ₹5.04 crore from ₹2.85 crore. Net profit increased ₹1.49 crore or 71.6% to ₹3.57 crore from ₹2.08 crore, while EPS rose to ₹2.0 from ₹0.54. The standalone half-year figures were revenue of ₹21.9 crore and profit after tax of ₹1.49 crore.
| ₹ crore | H1 FY27 | H1 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 43.27 | 30.19 | +43.3% |
| Profit before tax | 5.04 | 2.85 | +76.8% |
| Net profit | 3.57 | 2.08 | +71.6% |
| EPS (₹) | 2.00 | 0.54 | +270.4% |
Source: Company's results filing (XBRL).
What do the balance sheet and cash flow show?
At 30 September 2026, total assets were ₹77.36 crore, against ₹76.49 crore at 31 March 2026, while total equity rose to ₹62.14 crore from ₹58.08 crore. Borrowings fell to ₹1.95 crore from ₹10.8 crore, and cash declined to ₹2.61 crore from ₹7.56 crore.
Inventories fell to ₹5.75 crore from ₹6.75 crore. Trade receivables increased to ₹27.15 crore from ₹22.59 crore, while trade payables rose to ₹9.83 crore from ₹4.84 crore. The balance-sheet figures shown here are consolidated.
Operating cash flow in H1 FY27 was ₹4.88 crore, compared with negative ₹2.5 crore in H1 FY26. Investing cash flow was negative ₹0.97 crore against negative ₹8.41 crore, while financing cash flow was negative ₹8.86 crore against ₹5.57 crore. Capital expenditure was ₹1.02 crore, against ₹1.1 crore.
| ₹ crore | As of 30 September 2026 | As of 31 March 2026 |
|---|---|---|
| Total assets | 77.36 | 76.49 |
| Total equity | 62.14 | 58.08 |
| Borrowings | 1.95 | 10.80 |
| Cash and equivalents | 2.61 | 7.56 |
| Inventories | 5.75 | 6.75 |
| Trade receivables | 27.15 | 22.59 |
Source: Company's results filing (XBRL).
| ₹ crore | H1 FY27 | H1 FY26 |
|---|---|---|
| Cash from operations | 4.88 | −2.50 |
| Cash from investing | −0.97 | −8.41 |
| Cash from financing | −8.86 | 5.57 |
| Capital expenditure | 1.02 | 1.10 |
Source: Company's results filing (XBRL).
How has Hindcon Chemicals done over the last 8 quarters?
Revenue reached its highest level of the series in Q2 FY27 at ₹21.98 crore, after rising from ₹14.23 crore in Q3 FY26. The lowest revenue was ₹14.23 crore in Q3 FY26. Revenue and profit have each risen year on year for three consecutive quarters, according to the provided trend data.
Profit peaked at ₹2.34 crore in Q1 FY27 and fell to ₹1.23 crore in Q2 FY27. The EBITDA margin also peaked at 14.4% in Q1 FY27 before falling to 7.0%; its lowest point was 2.2% in Q3 FY26. The latest quarter therefore shows higher revenue but lower profit and margin than the preceding quarter.
How did other Specialty Chemicals companies do?
Among 60 Specialty Chemicals companies compared, the median revenue growth was 28.3%. Hindcon Chemicals’ 43.5% revenue growth was higher than that of 19 peers and lower than that of 41 peers.
Of the 56 peers for which profit was compared, 48 reported higher profit. These figures cover peer results available as of 5 November 2026 and exclude Hindcon Chemicals from the peer counts.
| Hindcon Chemicals revenue growth (YoY) | +43.5% |
|---|---|
| Median of 60 other Specialty Chemicals companies | +28.3% |
| Companies with slower revenue growth than Hindcon Chemicals | 41 of 60 |
| Companies with faster revenue growth than Hindcon Chemicals | 19 of 60 |
| Companies whose net profit rose | 48 of 56 |
Source: Filed results (XBRL) of the industry's companies.
Quick answers
What was Hindcon Chemicals' revenue in Q2 FY27?
Revenue from operations was ₹21.98 crore, up 43.5% from ₹15.32 crore in Q2 FY26 (consolidated).
Did Hindcon Chemicals make a profit in Q2 FY27?
Yes. Net profit was ₹1.23 crore, against a net profit of ₹0.72 crore in Q2 FY26.
What was Hindcon Chemicals' EPS in Q2 FY27?
Basic earnings per share were ₹0.37, against ₹0.19 in Q2 FY26.
When did Hindcon Chemicals announce its Q2 FY27 results?
On 5 November 2026, in a filing to the NSE.
Sources
- Outcome of Board Meeting (NSE, 5 November 2026) · PDF
How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.
This is information, not investment advice. MarketPing does not recommend buying or selling any security.